MarketAnalysisMarketAnalysis
NYSE:TMO

Thermo Fisher Scientific Inc. - NYSE:TMO - Comprehensive analysis

Free evaluation through quantitative algorithms Thermo Fisher Scientific Inc. - NYSE:TMO

Quant Rating

1

Strong Sell

2

Sell

3

Hold

4

Buy

5

Strong Buy


The overall quant rating is not an average of the factor grades listed.Instead, it gives greater weight to the metrics with the strongest predictive value.

Growth-Scoring Model Detail

Name

Fatcor
Percentage

Total Revenue Growth Over Prior Year

0.05

Market

26

Sector

45

Gross Profit Growth Over Prior Year

3.4

Market

37

Sector

50

EBITDA Growth Over Prior Year

-0.11

Market

26

Sector

29

EBITA Growth Over Prior Year

-1.03

Market

24

Sector

32

EBIT Growth Over Prior Year

3.88

Market

38

Sector

42

Earnings from Cont. Ops. Growth Over Prior Year

6.43

Market

51

Sector

46

Net Income Growth Over Prior Year

5.67

Market

49

Sector

47

Normalized Net Income Growth Over Prior Year

6.57

Market

52

Sector

42

Diluted EPS before Extra Growth Over Prior Year

6.99

Market

50

Sector

46

A/R Growth Over Prior Year

-0.39

Market

33

Sector

25

Inventory Growth Over Prior Year

-2.16

Market

26

Sector

21

PPE Net Growth Over Prior Year

-1.9

Market

25

Sector

54

Total Assets Growth Over Prior Year

-1.42

Market

27

Sector

45

Tangible Book Value Growth Over Prior Year

0

Market

0

Sector

0

Common Equity Growth Over Prior Year

6.1

Market

55

Sector

64

Cash from Ops. Growth Over Prior Year

3.1

Market

52

Sector

46

CAPEX Growth Over Prior Year

-5.34

Market

28

Sector

44

Dividend per Share Growth Over Prior Year

11.43

Market

86

Sector

99

Levered Free Cash Flow Growth Over Prior Year

28.3

Market

76

Sector

66

Unlevered Free Cash Flow Growth Over Prior Year

24.4

Market

73

Sector

65

Profitability-Scoring Model Detail

Name

Fatcor
Percentage

Gross Margin %

41.2

Market

47

Sector

44

SG&A Margin %

20

Market

65

Sector

33

EBITDA Margin %

25.1

Market

50

Sector

88

EBITA Margin %

22.4

Market

60

Sector

89

EBIT Margin %

17.88

Market

48

Sector

88

Earnings from Cont. Ops Margin %

14.78

Market

57

Sector

91

Net Income Margin %

14.77

Market

58

Sector

91

Net Income Avail. for Common Margin %

14.77

Market

59

Sector

91

Normalized Net Income Margin %

10.67

Market

54

Sector

89

Levered Free Cash Flow Margin %

15.37

Market

67

Sector

87

Unlevered Free Cash Flow Margin %

17.4

Market

68

Sector

88

Return on Assets %

4.89

Market

47

Sector

84

Return on Capital %

5.78

Market

36

Sector

82

Return on Equity %

13.13

Market

44

Sector

88

Return on Common Equity %

13.15

Market

44

Sector

88

Total Asset Turnover

0.44

Market

42

Sector

58

Sub-Scoring Model

Valuation
Momentum
Growth
Profitability
80
60
40
20
Valuation: 46
Momentum: 18
Growth: 44
Profitability: 53

Valuation-Scoring Model Detail

Name

Fatcor
Percentage

TEV/LTM Total Revenue

4.53

Market

60

Sector

62

TEV/LTM EBITDA

17.31

Market

71

Sector

82

P/LTM Normalized EPS

40

Market

71

Sector

67

P/BV

3.67

Market

53

Sector

72

TEV/LTM Unlevered FCF

26

Market

52

Sector

76

Momentum-Scoring Model Detail

Name

Fatcor
Percentage

1M Price Performance

-13.93

Market

12

Sector

48

3M Price Performance

-19.05

Market

17

Sector

58

6M Price Performance

-24.21

Market

18

Sector

55

9M Price Performance

-17.89

Market

24

Sector

67

1Y Price Performance

-21.67

Market

20

Sector

66

Start analyzing Thermo Fisher Scientific Inc. - NYSE:TMO with easy-to-understand research reports

Start analyzing Recent popular companies with easy-to-understand research reports